OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
28
Results
Show all
Save search
Copy query
Show results for
Unknown
(28)
Publication Date
Release Date
2022
(5)
2023
(4)
2021
(4)
2024
(3)
2025
(2)
2011
(2)
2008
(2)
2020
(1)
2018
(1)
2015
(1)
2013
(1)
2012
(1)
2009
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
The National Lung Screening Trial: overview and study design.
Not available
S-EPMC3009383
|
biostudies-literature
Cite
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
Not available
S-EPMC4570169
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
Not available
S-EPMC3641846
|
biostudies-literature
Cite
Mortality results from a randomized prostate-cancer screening trial.
Not available
S-EPMC2944770
|
biostudies-literature
Cite
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Not available
S-EPMC5972549
|
biostudies-literature
Cite
Effects of intensive glucose lowering in type 2 diabetes.
Not available
S-EPMC4551392
|
biostudies-literature
Cite
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Not available
S-EPMC10346130
|
biostudies-literature
Cite
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Not available
S-EPMC11117088
|
biostudies-literature
Cite
Risk of COVID-19 after natural infection or vaccination.
Not available
S-EPMC10518569
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets